SoCal's Vical Terminates 54% of Workforce to Focus Resources on Two Clinical Programs Post author:Sam Post published:January 30, 2018 Post category:BioPharma Vical announced its restructuring late Tuesday. Source: BioSpace You Might Also Like Bayer Head of Discovery Exits as Drugmaker Combines Pharma R&D Unit November 29, 2017 Lonza Group Unveils Agendia BV For 3rd Annual Global Endotoxin Testing Summit April 20, 2017 Boehringer Inks €627.5M Deal With GlaxoSmithKline Spinout December 17, 2017
